Identification of Plasma Proteins as Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease Using Liquid Chromatography–Tandem Mass Spectrometry

Blood proteins can be used for biomarkers to monitor the progression of cognitive decline, even in the early stages of disease. In this study, we developed a liquid chromatography–tandem mass spectrometry (LC-MS/MS)-based blood test to identify plasma proteins that can be used to detect mild cogniti...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Makoto, Suzuki, Hideaki, Meno, Kohji, Liu, Shan, Korenaga, Tatsumi, Uchida, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488247/
https://www.ncbi.nlm.nih.gov/pubmed/37685872
http://dx.doi.org/10.3390/ijms241713064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488247/
https://www.ncbi.nlm.nih.gov/pubmed/37685872
http://dx.doi.org/10.3390/ijms241713064

Ejemplares similares